中财网 中财网股票行情
泽璟制药(688266)财务分析指标    年份：
截止日期2026-06-302026-03-312025-12-312025-09-302025-06-30
营业总收入(万元)120537.9690539.1381048.4759344.0137565.03
营业收入(万元)120537.9690539.1381048.4759344.0137565.03
营业总成本(万元)59050.5727231.74102938.9972548.6147516.83
营业成本(万元)6458.932703.757763.385694.583882.09
净利润(万元)64003.8263260.63-16251.96-9395.40-7322.03
归属于母公司的净利润(万元)64001.1163261.26-16294.62-9341.62-7280.35
营业利润(万元)63866.2163228.72-16801.32-9676.26-7673.12
利润总额(万元)63864.6663177.06-16865.48-9831.96-7741.50
少数股东损益(万元)-----218.06-218.06-276.64
基本每股收益(元)2.42(元)2.39(元)-0.62(元)-0.35(元)-0.28(元)
稀释每股收益(元)2.42(元)2.39(元)-0.62(元)-0.35(元)-0.28(元)
非经常性损益(万元)2348.97----2726.28--
扣除非经常性损益后净利润(万元)61652.1463222.17-19785.52-12067.90-10264.14
总资产(万元)352624.01368838.61296918.56301337.74299920.34
总负债(万元)180575.37197533.17188873.74186436.36182258.79
归属于母公司股东权益合计(万元)172048.64171305.45108044.82114901.39117661.54
股东权益合计(万元)172048.64171305.45108044.82114901.39117661.54
实收资本(股本)(万元)26470.8226470.8226470.8226470.8226470.82
资本公积(万元)310947.65310947.65310947.65310947.65311634.44
未分配利润(万元)-163967.75-164707.61-227968.87-221015.87-218954.60
经营活动产生的现金流量净额(万元)80851.3983741.45-2878.20-1673.39-1702.03
经营活动现金流入小计(万元)149153.03114473.11105548.1676614.1647514.32
经营活动现金流出小计(万元)68301.6430731.66108426.3678287.5549216.35
投资活动产生的现金流量净额(万元)41243.80-60501.52-5563.44-6655.37-6234.26
投资活动现金流入小计(万元)201630.9142823.8712583.236594.351737.32
投资活动现金流出小计(万元)160387.11103325.3918146.6713249.727971.58
筹资活动产生的现金流量净额(万元)-33763.00-15798.17-750.10-68.502591.28
筹资活动现金流入小计(万元)5600.005600.00112688.2561602.1143152.11
筹资活动现金流出小计(万元)39363.0021398.17113438.3561670.6140560.83
期末现金及现金等价物余额(万元)100263.1019457.1512465.7713276.5316336.18
最后修改日期2026-08-012026-04-282026-03-282025-11-012025-08-22
↑返回页顶↑

转至泽璟制药（688266）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。